Oncology News

FDA approves Vepdegestrant (Veppanu) for ESR1-mutated breast cancer

FDA · estrogen receptor-positive, HER2-negative breast cancer · 6 min

SLS Stock Jumps on Biotech Momentum as SELLAS Gains 25.10%

4 min

Cardiff Oncology pipeline update: onvansertib trials, FDA meeting, and catalysts

FDA · oncology · 5 min

Tillomed Laboratories update: pipeline, melphalan and next catalysts

oncology · 6 min

Breast Cancer Statistics Worldwide: What the Data Shows

breast cancer · 6 min

Merck’s Harpoon acquisition deepens oncology pipeline ahead of Keytruda risk

oncology · 5 min

Johnson And Johnson ASCO 2026 Data Adds Depth To JNJ Valuation Story

oncology · 4 min

FDA Approves Companion Diagnostic for Inavolisib in HR+/HER2–, PIK3CA-Mutated Breast Cancer

FDA · oncology · 5 min

AstraZeneca and Daiichi's Datroway (Dato-DXd) Approved for Triple-Negative Breast Cancer: Implications for Pharma

FDA · breast cancer · 5 min

FDA Flashback: Key Breast Cancer Decisions from April 2026

FDA · breast cancer · 7 min

Legend Biotech surges on early in vivo CAR-T data for lymphoma

cell therapy · 5 min

FDA Approvals in Oncology: January-March 2026

FDA · oncology · 3 min